scFv antibodies (CNRS)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamescFv antibodies (CNRS)
Drug Alias NameA-5.31.F-1B-2.31.F-1C-3.3C-4.31.F-2H-2.1 +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre National De La Recherche Scientifique (Cnrs)
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCNRS InnovationCentre National De La Recherche Scientifique (Cnrs)
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A